Catalyst Wire Dossier Catalyst Wire Dossier

TETRAVAC-ACELLULAIRE

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TETRAVAC-ACELLULAIRE, covering 2017-09-11 to 2017-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE [Phase 4]

See pricing